Skip to main content

Table 2 General clinical and imaging data of patients

From: The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer

Agea

69(65–73)

tPSA(ng/ml)a

22.07(11.22–62.80)

PSA densitya

0.41(0.21–1.24)

Lesion location No.(%)

  CZ

94(46.53%)

  PZ

83(41.09%)

  CZ + PZ

25(12.38%)

Prostate Volume (ml)

52.12(38.33–72.49)

mean lesion size(mm)

15.2(11.1–24.6)

Number of cores of SB

1908 (87.36%)

Number of cores of TB

276 (12.64%)

  TB based on mpMRI only

62(2.84%)

  TB based on mpUS only

47(2.15%)

  TB based on both

167(7.65%)

  1. Tpsa total PSA, CZ Transition zone, PZ Peripheral zone
  2. aData are described by median (interquartile range)